Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy.
During a period of one year naltrexone was given to twenty-nine subjects. Fifteen of these subjects concurrently participated in a comprehensive behavior therapy program. The subjects in this naltrexone/behavior therapy group were maintanine on naltrexone for nearly twice as long as naltrexone group clients who received no therapy. If the chances for readdiction are reduced by increased time on naltrexone, then the data states the naltrexone should be dispensed as part of a broader therapeutic strategy. Follow-up data, which will be collected during the next year will test the validity of this hypothesis.
D000328:Adult; D001741:Black or African American; D001521:Behavior Therapy; D044383:Black People; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004651:Employment; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009294:Narcotics / Q000652:urine; D010349:Patient Compliance; D013030:Spain / Q000208:ethnology; D013334:Students
D009294:Narcotics; D009270:Naloxone; D009271:Naltrexone